Literature DB >> 16977343

Glutathione S-transferase M1 and GST T1 genetic polymorphisms and Raynaud's phenomenon in French vinyl chloride monomer-exposed workers.

Luc Fontana1,2, Marie-Jeanne Marion3, Sylvie Ughetto4, Pierre Catilina5.   

Abstract

Occupational vinyl chloride monomer (VCM) exposure can induce Raynaud's phenomenon (RP). However, not all VCM workers developed RP, which suggests an underlying genetic susceptibility. Genetic polymorphisms of glutathione S-transferases (GSTs), involved in VCM metabolism, have been shown to influence certain VCM-related health effects. We have conducted a case-control study of 58 subjects with RP along with 247 subjects without RP, from a population of 305 French workers exposed or formerly exposed to VCM, to assess any association between GST M1 and GST T1 gene polymorphisms, either separately or in combination, and the presence of RP. None of the GST M1 or GST T1 genotypes were significantly associated with the presence of RP among studied VCM workers. A combination of positive genotypes for both GST M1 and GST T1 was significantly associated with RP presence, compared to the other combinations of genotypes (OR=2.1, 95% CI=1.1-3.8). OR adjusted for age, smoking status, alcohol consumption and history of treated hypertension did not reach significance (OR=2.0, 95% CI=0.9-5.2). None of the GST M1 and GST T1 genotypes seem to contribute separately to the presence of RP, suggesting that they are not, when taken alone, a major determinant of interindividual variability for VCM-induced PR. However, the combination of both positive GST M1 and GST T1 genotypes appears to contribute slightly to susceptibility to RP in VCM-exposed subjects. Nevertheless, our study-the first to examine the role of a genetic component in the occurrence of RP secondary to occupational exposure to a chemical-corroborates the previous considerations that interaction between the genetic constitution and environmental factors is of importance in determining the health-adverse effects of VCM exposure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16977343     DOI: 10.1007/s10038-006-0038-9

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  34 in total

1.  Clinical manifestations and course of vinyl chloride disease.

Authors:  G Veltman; C E Lange; S Jühe; G Stein; U Bachner
Journal:  Ann N Y Acad Sci       Date:  1975-01-31       Impact factor: 5.691

Review 2.  Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response.

Authors:  H Autrup
Journal:  Mutat Res       Date:  2000-01-03       Impact factor: 2.433

3.  Clinical diagnosis found in patients with Raynaud's phenomenon: a multicentre study.

Authors:  W Grassi; R De Angelis; G Lapadula; G Leardini; R Scarpa
Journal:  Rheumatol Int       Date:  1998       Impact factor: 2.631

4.  Molecular epidemiology of p53 protein mutations in workers exposed to vinyl chloride.

Authors:  S J Smith; Y Li; R Whitley; M J Marion; S Partilo; W P Carney; P W Brandt-Rauf
Journal:  Am J Epidemiol       Date:  1998-02-01       Impact factor: 4.897

5.  Occupational acroosteolysis. Report of 31 cases.

Authors:  R H Wilson; W E McCormick; C F Tatum; J L Creech
Journal:  JAMA       Date:  1967-08-21       Impact factor: 56.272

6.  Angiographic study of digital arteries in workers exposed to vinyl chloride.

Authors:  P Falappa; N Magnavita; A Bergamaschi; N Colavita
Journal:  Br J Ind Med       Date:  1982-05

7.  Capillary abnormalities in polyvinyl chloride production workers. Examination by in vivo microscopy.

Authors:  H R Maricq; M N Johnson; C L Whetstone; E C LeRoy
Journal:  JAMA       Date:  1976-09-20       Impact factor: 56.272

8.  Genetic susceptibility to scleroderma-like syndrome in symptomatic and asymptomatic workers exposed to vinyl chloride.

Authors:  C Black; S Pereira; A McWhirter; K Welsh; R Laurent
Journal:  J Rheumatol       Date:  1986-12       Impact factor: 4.666

9.  Roles of 2-haloethylene oxides and 2-haloacetaldehydes derived from vinyl bromide and vinyl chloride in irreversible binding to protein and DNA.

Authors:  F P Guengerich; P S Mason; W T Stott; T R Fox; P G Watanabe
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

10.  Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study.

Authors:  Eric A Miller; James S Pankow; Robert C Millikan; Molly S Bray; Christie M Ballantyne; Douglas A Bell; Gerardo Heiss; Rongling Li
Journal:  Atherosclerosis       Date:  2003-12       Impact factor: 5.162

View more
  5 in total

Review 1.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

2.  The long-term effects of occupational exposure to vinyl chloride monomer on microcirculation: a cross-sectional study 15 years after retirement.

Authors:  Vincent Lopez; Alain Chamoux; Marion Tempier; Hélène Thiel; Sylvie Ughetto; Marion Trousselard; Geraldine Naughton; Frédéric Dutheil
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

Review 3.  Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.

Authors:  Manal M Fardoun; Joseph Nassif; Khodr Issa; Elias Baydoun; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-11-16       Impact factor: 5.810

Review 4.  Raynaud's Phenomenon: Reviewing the Pathophysiology and Management Strategies.

Authors:  Iqra Nawaz; Yashfa Nawaz; Eisha Nawaz; Muhammad Romail Manan; Adil Mahmood
Journal:  Cureus       Date:  2022-01-28

5.  Association of Raynaud's phenomenon with a polymorphism in the NOS1 gene.

Authors:  Sabrina Munir; Maxim B Freidin; Susan Brain; Frances M K Williams
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.